Skip to main content

Interactions of White Cells and the Humoral Cascades During Cardiopulmonary Bypass in Man

  • Chapter
Interaction of Cells with Natural and Foreign Surfaces
  • 39 Accesses

Abstract

For the past 30 years cardiopulmonary bypass has been used routinely for accurate repair of congenital and acquired cardiac defects. During this time the morbidity associated with both the surgical procedure and extracorporeal circulation itself have dramatically decreased and for some types of operation, such as coronary artery bypass grafting, the mortality approaches zero. However, damaging effects from cardiopulmonary bypass itself, still occur in every patient and especially in the very young, elderly or very sick patient may cause death, even after a successful cardiac repair.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. S. Westaby, Complement and the damaging effects of cardiopulmonary bypass, Thorax 38: 321–32 (1983).

    Article  Google Scholar 

  2. N.B. Ratliff, W.G. Young, D.B. Hackel, E. Mikat, and J.W. Wilson, Pulmonary injury secondary to extracorporeal circulation, J. Thorac. Cardiovasc. Surg. 75: 104–120 (1978).

    Google Scholar 

  3. A.S. Geha, A.D. Sessler, and J.W. Kirklin, Alveolar-arterial oxygen gradients after open cardiac surgery, J. Thorac. Cardiovasc. Surg. 51: 609–615 (1966).

    Google Scholar 

  4. P. Gailiunas, R. Chawla, J.M. Lazarus, L. Cohn, J. Sanders, and J.P. Merrill, Acute renal failure following cardiac operations, J. Thorac. Cardiovasc. Surg. 79: 241–243 (1980).

    Google Scholar 

  5. C.J. Lambert, A.J. Marengo-Rowe, J.E. Levenson, R.H. Green, J.P. Thiele, G.F. Geisler, M. Adam, and B.F. Mitchell, The treatment of postperfusion bleeding using E-aminocaprioc acid, cryoprecipitate, fresh frozen plasma and protamine sulphate, Ann Thorac. Surg. 28 440–444 (1979).

    Article  Google Scholar 

  6. F.B. Livelli, R.A. Johnson, and M.T. McEnany, Unexplained in-hospital fever following cardiac surgery, Circulation 57: 968–975 (1978).

    Google Scholar 

  7. H. Javid, H.M. Tufo, H. Jajafi, W.S. Dye, J.A. Hunter, and O.C. Julian, Neurological abnormalities following open heart surgery, J. Thorac. Cardiovasc. Surg. 58: 502–509 (1969).

    Google Scholar 

  8. Y. Tamari, L. Aledort, E. Puskin, T.J. Degnan, N. Wagner, M.J. Kaplitt, and E.C. Pierce, Functional changes in platelets during extracorporeal circulation, Ann. Thorac. Surg. 19: 639–647 (1975).

    Article  Google Scholar 

  9. R. McKenna, F. Bachmann, B. Whittaker, J.R. Gilson, and M. Weinberg, The haemostatic mechanism after open heart surgery II. Frequency of abnormal platelet functions during and after extracorporeal circulation, J. Thorac. Cardiovasc. Surg. 70: 298–308 (1975).

    Google Scholar 

  10. W.H. Lee, D. Krumbhaar, E.W. Fonkalsrud, O.A. Schjeide, and J.V. Maloney, Denaturation of plasma proteins as a cause of morbidity and death after intracardiac operations, Surgery 50: 29–39 (1961).

    Google Scholar 

  11. J. Feijen, Thrombogenesis caused by blood-foreign surface interaction, in: “Artificial Organs”, R.M. Kenedi, J.M. Courtney, J.D.S. Gaylor, and T. Gilchrist, ed, p. p. 235–247, University Park Press, Baltimore (1977).

    Google Scholar 

  12. G.N. Olinger, R.M. Becker, and L.I. Bonchek, Non cardiogenic pulmonary oedema and peripheral vascular collapse following cardiopulmonary bypass. Rare protamine reaction?, Ann. Thorac. Surg. 29: 20–25 (1980).

    Article  Google Scholar 

  13. D.J. Parker, S.W. Cantrell, R.B. Karp, R.M. Stroud, and S.B. Digerness, Changes in serum complement and immunoglobulins following cardiopulmonary bypass, Surgery 71: 824–827 (1972).

    Google Scholar 

  14. P. Hairston, J.P. Manos, C.D. Graber, and W.H. Lee, Depression of immunologic surveillance by pump oxygenation perfusion, Surg. Res. 9: 587–593 (1969).

    Article  Google Scholar 

  15. T.E. Hugli, Complement anaphylatoxins as plasma mediators, spasmogens and chemotaxins, in: “Current topics in molecular immunology”, R.N. Reisfield, and W.J. Mandy, ed, p. p. 255–279 Plenum Press, New York (1979).

    Google Scholar 

  16. D.E. Hammerschmidt, P.R. Craddock, J. McCullough, R.S.Kronenberg A.P. Dalmasso, and H.S. Jacob, Complement activation and pulmonary leukostasis during nylon fibre filtration leukaphorasis, Blood 51: 721–30 (1970).

    Google Scholar 

  17. P.R. Craddock, J. Fehr, K.L. Brigham, R.S. Kronenberg, and H.S. Jacob, Complement and leukocyte-mediated pulmonary dysfunction in haemodialysis, N. Engl. J. Med. 296: 769–774 (1974).

    Article  Google Scholar 

  18. D.E Hammerschmidt, D.F. Stroncek, T.K. Bowers, C.J. Lanni-Keefe, D.M. Kurth, A. Ozalins, D.M. Nicoloff, R.C. Lillehei, P.R. Craddock, and H.S. Jacob, Complement activation and neutropenia occurring during cardiopulmonary bypass, J. Thorac. Cardiovasc. Surg. 81: 370–377 (1981).

    Google Scholar 

  19. S.W. Fountain, B.S. Martin, C.E. Munsclow, and J.D. Cooper, Pulmonary leukostasis and its relationship to pulmonary dysfunction in sheep and rabbits, Circ. Res. 46: 175–180 (1980).

    Google Scholar 

  20. T.E. Hugli, and D.E. Chenoweth, Biologically active peptides of complement. Techniques and significance of C3a and C5a measurements, in: “Future perspectives in clinical laboratory immunoassays”, R.M. Nakamura, W.R. Dito and E.S. Tucker, ed, p. p. 443–460 Alan R. Liss, New York (1981).

    Google Scholar 

  21. D.E. Chenoweth, S.W. Cooper, T.E. Hugli, R.W. Stewart, E.H. Blackstone, and J.W. Kirklin, Complement activation during cardiopulmonary bypass. Evidence for generation of C3a and C5a anaphylatoxins, N. Engl. J. Med. 304: 497–503.

    Google Scholar 

  22. R. Rent, N. Ertel, R. Eisenstein, and H. Gewurz, Complement activation by interactions of polyanion and polycations I. Heparin-protamine induced consumption of complement, J. Immunol. 114: 120–124 (1975).

    Google Scholar 

  23. J.K. Kirklin, S. Westaby, E.H. Blackstone, J.W. Kirklin, D.E. Chenoweth, and A.D. Pacifico, Complement and the damaging effects of cardiopulmonary bypass, J. Thorac. Cardiovasc. Surg. 86: 845–857 (1983).

    Google Scholar 

  24. R.L. Replogle, A.B. Gazzaniga, and R.E. Gross, Use of corticosteroids during cardiopulmonary bypass. Possible lysosomal stabilisation, Circulation 33 and 34 (suppl. I): 86–92 (1966).

    Google Scholar 

  25. T. Sacks, C.F. Moldow, P.R. Craddock, T.K. Bowers, and H.S. Jacob, Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes, J. Clin. Invest. 61: 1161–1167 (1978).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Plenum Press, New York

About this chapter

Cite this chapter

Westaby, S. (1986). Interactions of White Cells and the Humoral Cascades During Cardiopulmonary Bypass in Man. In: Crawford, N., Taylor, D.E.M. (eds) Interaction of Cells with Natural and Foreign Surfaces. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2229-0_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-2229-0_11

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9307-1

  • Online ISBN: 978-1-4613-2229-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics